The CCR2+ macrophage subset has pro-angiogenic properties in HCC, and inhibition of CCR2+ TAMs in the fibrosis-HCC model significantly suppress angiogenic activities (44). This evidence concerns the gene CCR2 and hepatocellular carcinoma.